Insights+ Key Biosimilars Events of November 2022
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...
Top Performing Drug of 2021 – Xarelto (November Edition)
Active Ingredient: rivaroxaban Strength: 2.5 mg, 10 mg, 15 mg, and...
Insights+: EMA Marketing Authorization of New Drugs in October 2022
The EMA approved 2 Biologic Drugs in October 2022, leading to treatments for patients and advances in the hea...
Insights+: The US FDA New Drug Approvals in October 2022
The US FDA approved 1 NDAs and 2 BLA in October 2022, leading to treatments for patients and advances in the...
Disease of the Month: Epilepsy | PharmaShots
INTRODUCTION Also known as seizure disorder, epilepsy is a non-communicable chronic disord...
Insights+ Key Biosimilars Events of October 2022
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...
